SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

49.9768362

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

28.6

EPS(TTM)

Face Value()

Div & Yield %

Back

Dhansafal Finserve reports standalone net profit of Rs 0.18 crore in the December 2025 quarter

Feb 14,2026

Net profit of Dhansafal Finserve reported to Rs 0.18 crore in the quarter ended December 2025 as against net loss of Rs 0.13 crore during the previous quarter ended December 2024. Sales rose 198.31% to Rs 3.52 crore in the quarter ended December 2025 as against Rs 1.18 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3.52	1.18	198
OPM %	33.52	-22.88	-
PBDT	0.47	-0.09	LP
PBT	0.26	-0.10	LP
NP	0.18	-0.13	LP

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)